In summary, the findings reported here indicate that EIF4EBP1 is a direct target gene of MYCN in NB, explaining the observed high expression of EIF4EBP1 in NB, and that EIF4EBP1 mRNA and protein expression have prognostic values in NB patients, especially for stratifying high-risk NB patients. Here, MYCN is linked to neuroblastoma.